These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37606251)

  • 1. A supervised machine-learning approach for the efficient development of a multi method (LC-MS) for a large number of drugs and subsets thereof: focus on oral antitumor agents.
    Kehl N; Gessner A; Maas R; Fromm MF; Taudte RV
    Clin Chem Lab Med; 2024 Jan; 62(2):293-302. PubMed ID: 37606251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
    Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.
    Poetto AS; Posocco B; Gagno S; Orleni M; Zanchetta M; Iacuzzi V; Canil G; Buzzo M; Montico M; Guardascione M; Basile D; Pelizzari G; Alberti M; Gerratana L; Puglisi F; Toffoli G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122985. PubMed ID: 34700133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioanalytical LC-MS/MS validation of therapeutic drug monitoring assays in oncology.
    van Nuland M; Rosing H; Schellens JHM; Beijnen JH
    Biomed Chromatogr; 2020 Jan; 34(1):e4623. PubMed ID: 31215049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of 5- fluorouracil, capecitabine and its metabolite concentrations in blood using volumetric absorptive microsampling technology and LC-MS/MS.
    Radovanovic M; Schneider JJ; Shafiei M; Martin JH; Galettis P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan; 1188():123075. PubMed ID: 34891049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
    Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
    Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
    J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Novel Analytical Method for Determining Trazodone in Human Plasma by Liquid Chromatography Coupled With Mass Spectrometry Coupled With Automatic 2-Dimensional Liquid Chromatograph-Mass Spectrometer Coupler 9500 and Its Application to Therapeutic Drug Monitoring.
    Ding J; Zhang Y; Cui X; Zhao C; Zhang S
    Ther Drug Monit; 2022 Jun; 44(3):465-473. PubMed ID: 34469419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in antifungal drug measurement by liquid chromatography-mass spectrometry.
    Zheng YZ; Wang S
    Clin Chim Acta; 2019 Apr; 491():132-145. PubMed ID: 30685359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning liquid chromatography retention time prediction model augments the dansylation strategy for metabolite analysis of urine samples.
    Choi E; Yoo WJ; Jang HY; Kim TY; Lee SK; Oh HB
    J Chromatogr A; 2023 Aug; 1705():464167. PubMed ID: 37348224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated HPLC-MS/MS assay for the simultaneous determination of ten plasma antibiotic concentrations.
    Magréault S; Jaureguy F; Zahar JR; Méchaï F; Toinon D; Cohen Y; Carbonnelle E; Jullien V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1211():123496. PubMed ID: 36244237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teaching a New Dog Old Tricks: Ultrafast Liquid Chromatography/Tandem-Mass Spectrometry Analysis of Nine ß-Lactam Antibiotics for Improved Therapeutic Drug Monitoring.
    Hodgkins C; Cordwell SJ; Kocic D
    Ther Drug Monit; 2022 Dec; 44(6):777-783. PubMed ID: 36372935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A LC-MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinoma.
    Iacuzzi V; Zanchetta M; Gagno S; Poetto AS; Orleni M; Marangon E; Guardascione M; Foltran L; Posocco B; Toffoli G
    J Pharm Biomed Anal; 2020 Aug; 187():113358. PubMed ID: 32460216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a liquid chromatography coupled to tandem mass spectrometry method for the monitoring of temsavir plasma concentrations in people living with HIV.
    Thoueille P; Seybold U; Decosterd LA; Desfontaine V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1214():123575. PubMed ID: 36542988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients.
    Barco S; Mesini A; Barbagallo L; Maffia A; Tripodi G; Pea F; Saffioti C; Castagnola E; Cangemi G
    J Pharm Biomed Anal; 2020 Jul; 186():113273. PubMed ID: 32251979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of an analytical method using liquid chromatography-tandem mass spectrometry for the therapeutic drug monitoring of seven cardiovascular drugs in clinical usage.
    Abady MM; Jeong JS; Kwon HJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1214():123552. PubMed ID: 36469961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of an LC-MS/MS assay for rapid and simultaneous quantification of 21 kinase inhibitors in human plasma and serum for therapeutic drug monitoring.
    Al Shirity ZN; Westra N; Hateren KV; Munnink THO; Kosterink JGW; Mian P; Hooge MNL; Touw DJ; Gareb B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Sep; 1229():123872. PubMed ID: 37716342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring.
    Zanchetta M; Iacuzzi V; Posocco B; Bortolin G; Poetto AS; Orleni M; Canil G; Guardascione M; Foltran L; Fanotto V; Puglisi F; Gagno S; Toffoli G
    PLoS One; 2021; 16(10):e0259137. PubMed ID: 34699578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
    Decosterd LA; Mercier T; Ternon B; Cruchon S; Guignard N; Lahrichi S; Pesse B; Rochat B; Burger R; Lamoth F; Pagani JL; Eggimann P; Csajka C; Choong E; Buclin T; Widmer N; André P; Marchetti O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1157():122160. PubMed ID: 32891946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs.
    Kuhlin J; Sturkenboom MGG; Ghimire S; Margineanu I; van den Elsen SHJ; Simbar N; Akkerman OW; Jongedijk EM; Koster RA; Bruchfeld J; Touw DJ; Alffenaar JC
    Clin Mass Spectrom; 2019 Sep; 14 Pt A():34-45. PubMed ID: 34934812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.